Skip to main content
. 2015 Oct 12;6(33):34300–34308. doi: 10.18632/oncotarget.5549

Figure 3. Recurrence-free survival.

Figure 3

A. and overall survival B. according to FGFR fusion and mutation status. FGFR (+), either FGFR fusion or FGFR mutation was positive; FGFR (−), both FGFR fusion and FGFR mutation were negative.